We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Millipore Expands Collection of Lipid Kinases

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Millipore Corporation has announced the expansion of its PI3 kinase line, making it the broadest panel of lipid kinases available worldwide. Millipore now offers 17 lipid kinases, available both for purchase and as part of its gold-standard KinaseProfiler™ service.

PI3 kinases regulate a wide variety of cellular functions, including cell growth, proliferation, differentiation, motility, survival, and intracellular trafficking. As a result, defects in PI3 kinase function lead to multiple disease states, including several forms of cancer.

Millipore’s lipid kinase panel and KinaseProfiler service provide the tools to dissect the networks underlying PI3 kinase signaling, essential to the design of new therapies.

Combined with Millipore’s PI3 Kinase HTRF™ Assay, KinaseProfiler service, and small-molecule inhibitors, the expanded lipid kinase panel can provide researchers with the complete solution to studying lipid kinase signaling. The new lipid kinase panel includes both wild type and disease-linked mutants.